Preview

Эндокринные и метаболические аспекты ведения пациентов, перенесших бариатрические операции.По материалам Клинических рекомендаций Общества эндокринологов

https://doi.org/10.14341/2071-8713-5060

Полный текст:

Аннотация

Заболеваемость морбидным ожирением увеличивается во всем мире. На этом фоне широкое распространение получили хирургические методы лечения ожирения. Зачастую после бариатрических вмешательств пациент сталкивается с целым рядом проблем, требующих пожизненного контроля и терапии. Обществом эндокринологов были разработаны детальные рекомендации по ведению пациентов после хирургического лечения ожирения. В данной статье изложены и прокомментированы их основные положения.

Список литературы

1. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guideline for clinical management of diabetes mellitus. Endocr Pract 2004; 10: 112-118.

2. Aasheim E, Hofso D, Hjelmesaeth J, Birkeland K, Bohmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 2008; 87: 362-9.

3. American association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic and non-surgical support of the bariatric surgery patient. Surg Obes Relat Dis 2008; 4(5 Suppl): S109-84.

4. Anderson J, Konz E, Frederich R, et al. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001; 74: 579-84.

5. Angstadt J, Bodziner R. Peripheral polyneuropathy from thiamine deficiency following laparoscopic Roux-en-Y gastric bypass. Obes Surg 2005; 15: 890-892.

6. Avenell A, Brown T, McGee M, et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet 2004; 17: 317-35.

7. Brechner R, Farris C, Harrison S, et al. A graded evidence-based summary of evidence for bariatric surgery. Surg Obes Relat Dis 2005; 1: 430-441.

8. Brolin R, Bradely L, Wilson A, et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastroenterol Surg 2000; 4: 464-69.

9. Brolin R, Gorman J, Gorman R, et al. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Arch Surg 1998; 133: 740-744.

10. Brolin R, Kenler H, Wilson A, et al. Serum lipids after gastric bypass surgery for morbid obesity. Int J Obes 1990; 14: 939-50.

11. Brolin R, Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg 1999; 9: 150-154.

12. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.

13. Byrne T. Complications of surgery for obesity. Surg Clin North Am 2001; 81: 1181-193, VII-VIII.

14. Carlin A, Rao D, Meslemani A, Genaw J, Parikh N, Levy S, Bhan A, Talpos G. Prevalence of vitamin D depletion among morbidly obese patients sеeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 98-103.

15. Carlin A, Rao D, Yager K, et al. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis 2009; 5(4): 444-9.

16. Clements R, Yellumahanthi K, Wesley M, et al. Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass. Am Surg 2008; 74(6): 474-475.

17. Collazo-Clavell M, Jimenez A, Hodson S, et al. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract 2004; 10: 195-198.

18. Cummings D, Overduin J, Foster-Schubert K, et al. Role of the bypassed proximal intestine in the antidiabetic effects of bariatric surgery. Surg Obes Relat Dis 2007; 3: 109-115.

19. Davies D, Baxter JM, Baxter JN. Nutritional deficiencies after bariatric surgery Obes Surg 2007; 17: 1150-1158.

20. Dixon J, O'Brien P, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316-323.

21. Douketis J, Macie C, Thabane L, et al. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes (Lond) 2005; 29: 1153-67.

22. Dronge A, Percal H, Kancir S, et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141: 375-380.

23. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95: 4823-43.

24. Ernst B, Thurnheer M, Schmid S, et al. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66-73.

25. Fleischer J, Stein EM, Bessler M, Della Badia M, Restuccia N, Olivero-Rivera L, McMahon DJ, Silverberg SJ. The Decline in Hip Bone Density after Gastric Bypass Surgery Is Associated with Extent of Weight Loss J Clin EndocrinolMetab 2008; 93: 3735-3740.

26. Gasteyger C, Suter H, Gaillard R, et al. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standart multivitamin supplementation. Am J Clin Nutr 2008; 87: 1128-33.

27. Goldfine A, Mun E, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin responses to a mixed meal. J Clin Endocrinol Metab 2007; 92: 4678-85.

28. Goldner W, Stoner J, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective randomized pilot clinical trial. Obes Surg 2009; 19(2): 173-179.

29. Guh D, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88.

30. Herpertz S, Kielmann R, Wolf A, et al. Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. Obes Res 2004;12: 1554-69.

31. Higgins M, D'Agostino R, Kannel W, et al. Benefits and adverse effects of weight loss: observations from the Framingham study. Ann Intern Med 1993; 119: 758-63.

32. Hsu L, Benotti P, Dwyer J. Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med 1998; 60: 338-46

33. Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg 2007; 17: 260-70.

34. Johnson M, Maher J, DeMaria E, Downs R, Wolfe L, Kellum J. The Long-term Effects of Gastric Bypass on Vitamin D Metabolism. Ann Surg 2006;243: 701-705.

35. Kalarchian M, Marcus M, Levine M, et al. Relationship of psychiatric disorders to 6-month outcomes after gastric bypass. Surg Obes Relat Dis 2008; 4: 544-9.

36. Laferrere B, Teixeira j, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-2485.

37. Larrad-Jimenez A, Diaz-Guerra C, de Cuadros Borrajo P, et al. Short-, mid-, and long-term results of Larrad biliopancreatic diversion. Obes Surg 2007; 17: 202-210.

38. Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int 2009; 106: 641-648.

39. Magro D, Gelonese B, Delfini R, et al. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg 2008; 18: 648-651.

40. Must A, Spadano J, Coakley E, et al. The disease burden associated with overweight and obesity. JAMA 1999, 282, 1523-1529.

41. Ogden C, Carroll M, Curtin L, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.

42. Orzano A, Scott J. Diagnosis and treatment of obesity in adults: an applied evidence based review. J Am Board Fam Pract 2004; 17: 359-69.

43. Pamuk E, Serdula M, et al. Weight loss and subsequent death in a cohort of US adults, 1971-1987. Ann Intern Med 1993; 119: 744-8.

44. Pajecki D, Dalcanalle L, Souza de Oliveira C, et al. Follow-up of Roux-en-Y gastric bypass patientsat 5 or more years post-operatively. Obes Surg 2007; 17: 601-607.

45. Rhode B, Arseneau P, Cooper B, et al. Vitamin B-12 deficiency after gastric surgery for obesity. Am J Clin Nutr 1996; 63: 103-109.

46. Rubino F, Gagner M, Gentileschi P, et al. The early effect of Roux-en-Y gastric bypass on hormones is involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236-242.

47. Sarwer D, Cohn N, Gibbons L, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg 2004; 14: 1148-56.

48. Service G, Thompson G, Service F, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric bypass surgery. N Engl J Med 2005; 353: 249-54.

49. Singh S, Kumar A. Wernicke encephalopathy from thiamine deficiency after obesity surgery: a systematic review. Neurology 2007; 68: 807-811.

50. Sjostrom L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.

51. Sjostrom L, Narbo K, Sjostrom D, et al. Effects of bariatric surgery on mortality in Swedish Obese Subjects. N Engl J Med 2007; 357: 741-52.

52. Skroubis G, Sakellapoulos G, Pouggouras K, et al. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg 2002; 12: 551-558.

53. Slater G, Ren C, Siegel N, et al. Serum fat soluble vitamin deficiency and abnormal calcium metabolism after malabsorbtive bariatric surgery. J Gastrointest Surg 2004; 8: 48-55.

54. Stoker D. Management of the bariatric surgery patient. Endocrinol Meatb Clin North Am 2003; 32: 437-457.

55. Summerbell C, Cameron C, Glasziou P. WITHDRAWN: Advice on low-fat diets for obesity. Cochrane Database Syst Rev 2008; 16: CD003640.

56. Tice J, Karliner L, Walsh J, et al. Gastric binding or gastric bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121: 885-893.

57. Tindle H, Omalu B, Courcoulas A, et al. Risk of suicide after long-term follow-up from bariatric surgery. Am J Med. 2010; 123: 1036-42.

58. Van Hout G, Verschure S, Van Heck G. Psychosocial predictors of success following bariatric surgery. Obes Surg 2005; 15(4): 552-60.

59. Wadden T, Sarwer D. Behavioral Assessment of Candidates for Bariatric Surgery: A Patient-Oriented Approach. Obesity 2006; 14 (Suppl): 53S-62S.

60. Williamson D, Pamuk E, Thun M, et al. Prospective study of intentional weight loss and mortality in never smoking overweight US white women aged 40-64 years. Am J Epidemiol 1995; 141: 1128-41.

61. Williamson D, Pamuk E, Thun M, et al. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol 1999; 149: 491-503.

62. Ybarra J, Sanchez-Hernandez J, Gich I, De Leiva A, Rius X, Rodríguez-Espinosa J, Perez A. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 2005; 15: 330-335.

63. Ybarra J, Sanchez-Hernandez J, Perez A Hypovitaminosis D and morbid obesity. Nurs Clin North Am 2007; 42: 19-27.

64. Youssef Y, Richards WO, Sekhar N, Kaiser J, Spagnoli A, Abumrad N, Torquati A. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 2007; 21: 1393-1396.


Для цитирования:


Mazurina N.V., Sviridonova M.A. Эндокринные и метаболические аспекты ведения пациентов, перенесших бариатрические операции.По материалам Клинических рекомендаций Общества эндокринологов. Ожирение и метаболизм. 2012;9(1):51-57. https://doi.org/10.14341/2071-8713-5060

For citation:


., . Endocrine and metabolic aspects of the management of patients undergoing bariatric surgery. Review of clinical recommendations. Obesity and metabolism. 2012;9(1):51-57. (In Russ.) https://doi.org/10.14341/2071-8713-5060

Просмотров: 26


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)